VCM
CNMD icon

Versant Capital Management’s CONMED CNMD Stock Holding History

Versant Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.8K Buy
1,125
+763
+211% +$27.5K ﹤0.01% 1576
2026
Q1 		$12.8K Buy
362
+202
+126% +$8.22K ﹤0.01% 2030
2025
Q4 		$6.5K Sell
160
-72
-31% -$3.13K ﹤0.01% 2156
2025
Q3 		$10.9K Buy
232
+8
+4% +$415 ﹤0.01% 1902
2025
Q2 		$11.7K Buy
224
+165
+280% +$9.05K ﹤0.01% 1819
2025
Q1 		$3.56K Buy
59
+36
+157% +$2.32K ﹤0.01% 2152
2024
Q4 		$1.57K Sell
23
-12
-34% -$836 ﹤0.01% 2104
2024
Q3 		$2.52K Buy
35
+12
+52% +$847 ﹤0.01% 1508
2024
Q2 		$1.59K Sell
23
-24
-51% -$1.75K ﹤0.01% 1562
2024
Q1 		$3.76K Sell
47
-16
-25% -$1.43K ﹤0.01% 1143
2023
Q4 		$6.9K Buy
63
+16
+34% +$1.65K ﹤0.01% 871
2023
Q3 		$4.74K Sell
47
-86
-65% -$9.88K ﹤0.01% 999
2023
Q2 		$18.1K Buy
133
+86
+183% +$10.5K 0.01% 541
2023
Q1 		$4.86K Hold
47
– – ﹤0.01% 947
2022
Q4 		$4.17K Buy
47
+5
+12% +$415 ﹤0.01% 943
2022
Q3 		$3K Sell
42
-79
-65% -$7.45K ﹤0.01% 961
2022
Q2 		$12K Buy
121
+10
+9% +$1.2K ﹤0.01% 594
2022
Q1 		$16K Sell
111
-10
-8% -$1.4K 0.01% 533
2021
Q4 		$17K Buy
121
+12
+11% +$1.7K 0.01% 543
2021
Q3 		$14K Sell
109
-23
-17% -$3.01K ﹤0.01% 594
2021
Q2 		$18K Buy
132
+57
+76% +$7.8K 0.01% 511
2021
Q1 		$10K Buy
75
+55
+275% +$6.62K ﹤0.01% 780
2020
Q4 		$2K Buy
20
+3
+18% +$284 ﹤0.01% 1101
2020
Q3 		$1K Hold
17
– – ﹤0.01% 1153
2020
Q2 		$1K Hold
17
– – ﹤0.01% 1149
2020
Q1 		$0 Sell
17
-89
-84% -$8.21K ﹤0.01% 1353
2019
Q4 		$11K Buy
106
+7
+7% +$746 0.01% 652
2019
Q3 		$9K Sell
99
-47
-32% -$4.41K ﹤0.01% 744
2019
Q2 		$12K Sell
146
-345
-70% -$28.4K 0.01% 659
2019
Q1 		$40K Sell
491
-595
-55% -$43.2K 0.02% 336
2018
Q4 		$69K Hold
1,086
– – 0.03% 177
2018
Q3 		$86K Hold
1,086
– – 0.04% 166
2018
Q2 		$79K Sell
1,086
-4
-0.4% -$272 0.03% 184
2018
Q1 		$69K Sell
1,090
-7
-0.6% -$418 0.03% 207
2017
Q4 		$55K Hold
1,097
– – 0.02% 277
2017
Q3 		$57K Hold
1,097
– – 0.03% 229
2017
Q2 		$55K Sell
1,097
-27
-2% -$1.34K 0.03% 230
2017
Q1 		$49K Hold
1,124
– – 0.03% 274
2016
Q4 		$49K Sell
1,124
-3
-0.3% -$127 0.03% 292
2016
Q3 		$45K Buy
1,127
+4
+0.4% +$170 0.03% 281
2016
Q2 		$53K Sell
1,123
-94
-8% -$3.98K 0.03% 221
2016
Q1 		$51K Sell
1,217
-83
-6% -$3.26K 0.03% 233
2015
Q4 		$57K Buy
+1,300
New +$56.4K 0.04% 201

Other funds holding CNMD

WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
EP
EPIQ Partners Minneapolis, Minnesota $236M AUM 15.39% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
FAM
Fenimore Asset Management Cobleskill, New York $4.83B AUM 9.09% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Versant Capital Management's CNMD Position: Q2 2026 in Review

Versant Capital Management increased its CONMED (CNMD) stake by 211% in Q2 2026, buying an estimated $27.5K and bringing the position to 1,125 shares worth $36.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1576.

Versant Capital Management first reported a position in CNMD in Q4 2015 and has held it in 43 quarters since. The position peaked at $86K in Q3 2018. 23 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Versant Capital Management held 1,125 shares of CONMED worth $36.8K as of Q2 2026.
  • Versant Capital Management bought 763 CONMED shares in Q2 2026, an estimated $27.5K.
  • CONMED made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #1576 holding.
  • Versant Capital Management first reported a position in CONMED in Q4 2015 and has held it in 43 quarters since.
  • Versant Capital Management's CONMED position peaked at $86K in Q3 2018.
  • 23 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.